Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Female
Humans
Karyotype
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Nuclear Proteins
Prognosis
RNA, Messenger
Survival Analysis
Tandem Repeat Sequences
Treatment Outcome
fms-Like Tyrosine Kinase 3
